Verici DX (VRCI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 2.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 8.75
  • 52 Week Low: 2.25
  • Currency: UK Pounds
  • Shares Issued: 242.54m
  • Volume: 0
  • Market Cap: £6.67m
  • RiskGrade: 429
  • Beta: 0.00

Verici DX Overview

Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.

1 Day Chart (01-04-2025)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -875.3% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 6.6 n/a
Pr/Book 1.9  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Verici DX Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 n/a (4.74) (5.46)¢ n/a n/a n/a n/a 0.0%
31-Dec-21 n/a (8.33) (5.90)¢ n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (11.41) (6.90)¢ n/a n/a n/a n/a 0.0%
31-Dec-23 1.01 (8.73) (5.10)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Verici DX Company Announcements

Holding(s) in Company 14-Jan-2025 11:01 RNS
Update on Local Coverage Determination and Trading 11-Oct-2024 07:00 RNS
Launch of PTRA Assay using Verici Dx's technology 31-Jul-2024 07:00 RNS

Verici DX ShareCast News

Verici Dx announces delay to Medicare determinat... 11-Oct-2024 ShareCast
Verici Dx reaches Thermo Fisher collaboration mi... 01-Jul-2024 ShareCast
Verici Dx completes analytical validation on two... 15-Feb-2022 ShareCast

Latest Verici DX Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Verici DX Market Data

Currency UK Pounds
Share Price 2.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 8.75
52 Week Low 2.25
Volume 0
Shares Issued 242.54m
Market Cap £6.67m
Beta 0.00
RiskGrade 429

Verici DX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
33.99% below the market average33.99% below the market average33.99% below the market average33.99% below the market average33.99% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average
Price Trend
92.19% below the market average92.19% below the market average92.19% below the market average92.19% below the market average92.19% below the market average
75.51% below the sector average75.51% below the sector average75.51% below the sector average75.51% below the sector average75.51% below the sector average
Income Not Available
Growth Not Available

Verici DX Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

Verici DX Key Personnel

CEO Sara Barrington

Top of Page